Apostolia Maria Tsimberidou, Farshid Dayyani, David Sommerhalder, Andrae L. Vandross, Meredith Pelster, Cesar Augusto Perez, Chandtip Chandhasin, Yiyun Dai, Shirley Tu, Ivan King, Frank Perabo. "Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors: Results on safety, pharmacokinetics, and anti-tumor activity.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3124